Short Interest in Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) Declines By 88.1%

Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) saw a significant decline in short interest in the month of May. As of May 15th, there was short interest totaling 36,079 shares, a decline of 88.1% from the April 30th total of 303,052 shares. Currently, 0.9% of the shares of the company are short sold. Based on an average daily trading volume, of 676,732 shares, the days-to-cover ratio is presently 0.1 days.

Institutional Trading of Defiance Daily Target 2X Long LLY ETF

A hedge fund recently bought a new stake in Defiance Daily Target 2X Long LLY ETF stock. Thurston Springer Miller Herd & Titak Inc. purchased a new position in Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 5,433 shares of the company’s stock, valued at approximately $138,000. Thurston Springer Miller Herd & Titak Inc. owned 0.34% of Defiance Daily Target 2X Long LLY ETF at the end of the most recent reporting period.

Defiance Daily Target 2X Long LLY ETF Stock Performance

NYSEARCA LLYX traded up $1.88 during trading hours on Thursday, hitting $25.01. 501,864 shares of the company’s stock traded hands, compared to its average volume of 466,036. The business’s fifty day moving average price is $18.18 and its two-hundred day moving average price is $21.86. Defiance Daily Target 2X Long LLY ETF has a 52 week low of $9.60 and a 52 week high of $28.44.

About Defiance Daily Target 2X Long LLY ETF

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.